Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Gary Mather"'
Autor:
Apostolia Maria Tsimberidou, Matthias C. Schabel, Terri Warren, David S. Hong, Razelle Kurzrock, Anil Chhabra, Gary Mather, Cynthia Uehara, Brent A. Evans, Edward Swabb, Deane Woodland, Wallace Akerley
Publikováno v:
Molecular Cancer Therapeutics. 9:3410-3419
MPC-6827 (Azixa) is a small-molecule microtubule-destabilizing agent that binds to the same (or nearby) sites on β-tubulin as colchicine. This phase I study was designed to determine the dose-limiting toxicities (DLT), maximum tolerated dose (MTD),
Autor:
John Drewe, Kevin Jessing, Raouf A. Hussain, Christopher M. Pleiman, Khanh C. Hoang, Nilantha Sudath Sirisoma, Songchun Jiang, Gary Mather, Hong Zhang, Azra Pervin, Ben Tseng, Vijay Baichwal, Shailaja Kasibhatla, J. Adam Willardsen, Sui Xiong Cai, Mark B. Anderson
Publikováno v:
Journal of Medicinal Chemistry. 51:4771-4779
Using a live cell, high-throughput caspase-3 activator assay, we have identified a novel series of 4-anilinoquinazolines as inducers of apoptosis. In this report, we discuss the discovery of 2-chloro-N-(4-methoxyphenyl)-N-methylquinazolin-4-amine, co
Autor:
John Drewe, Gary Mather, Hong Zhang, Christopher M. Pleiman, Songchun Jiang, Azra Pervin, Ben Tseng, Sui Xiong Cai, Mark B. Anderson, Shailaja Kasibhatla, J. Adam Willardsen, Nilantha Sudath Sirisoma
Publikováno v:
Bioorganicmedicinal chemistry letters. 20(7)
As a continuation of our efforts to discover and develop apoptosis inducing N-methyl-4-(4-methoxyanilino)quinazolines as novel anticancer agents, we explored substitution at the 5-, 6-, 7-positions of the quinazoline and replacement of the quinazolin
Autor:
Mark B. Anderson, Azra Pervin, Nilantha Sudath Sirisoma, Sui Xiong Cai, Ben Tseng, Hong Zhang, Gary Mather, Songchun Jiang, John Drewe, J. Adam Willardsen, Shailaja Kasibhatla, Christopher M. Pleiman
Publikováno v:
Journal of medicinal chemistry. 52(8)
As a continuation of our structure-activity relationship (SAR) studies on 4-anilinoquinazolines as potent apoptosis inducers and to identify anticancer development candidates, we explored the replacement of the 2-Cl group in our lead compound 2-chlor
Publikováno v:
Alzheimer's & Dementia. 4
Publikováno v:
Alzheimer's & Dementia. 4
Publikováno v:
Alzheimer's & Dementia. 4
Publikováno v:
Alzheimer's & Dementia. 4
P4‐395: Inhibition of CYP2C9 by fluconazole reduces clearance and increases exposure to tarenflurbil
Publikováno v:
Alzheimer's & Dementia. 4
Publikováno v:
Alzheimer's & Dementia. 4